Multiple Myeloma Posts on Medivizor
Navigation Menu

Multiple Myeloma Posts on Medivizor

Searching for patients with recurrent multiple myeloma to test daratumumab

Posted by on May 24, 2019 in Multiple Myeloma | 0 comments

In a nutshell This phase 2 trial is evaluating how well daratumumab (Darzalex) works in treating patients with multiple myeloma (MM) that has come back after a stem cell transplant (SCT). The main outcome to be measured will be the number of patients who have a complete disappearance of all signs of cancer. This trial is recruiting in Houston,...

Read More

Evaluating busulfan plus melphalan conditioning for patients with multiple myeloma before stem cell transplantation

Posted by on May 20, 2019 in Multiple Myeloma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of busulfan (Myleran) plus melphalan (Alkeran) compared to melphalan alone for patients with multiple myeloma (MM) before autologous stem cell transplantation (ASCT). This study concluded that the combination treatment was more effective for these patients. Some background...

Read More

Evaluating isatuximab plus pomalidomide and dexamethasone for non-responsive multiple myeloma

Posted by on May 11, 2019 in Multiple Myeloma | 0 comments

In a nutshell This study evaluated  isatuximab, pomalidomide (Imnovid) and dexamethasone (Decadron) for recurrent or non-responsive multiple myeloma (MM). This study concluded that this treatment combination was safe and effective for these patients. Some background There are several treatment options for patients with MM. Most initial...

Read More

Does genetics impact how long patients respond to treatment for recurrent multiple myeloma?

Posted by on May 2, 2019 in Multiple Myeloma | 0 comments

In a nutshell This study evaluated whether certain genetic markers affect how long patients respond to treatment for recurrent multiple myeloma (MM). This study found that patients without these genetic markers had better outcomes compared to patients who did have them. Some background Multiple myeloma is a type of cancer of the bone marrow that can...

Read More

Expert recommendations for the treatment of patients with multiple myeloma.

Posted by on Apr 30, 2019 in Multiple Myeloma | 0 comments

In a nutshell This article provided recommendations for the treatment of patients with multiple myeloma (MM). Some background Multiple myeloma is a type of cancer of the bone marrow that can lead to abnormal immune cells. High-dose chemotherapy followed by a stem cell transplant (SCT) remains a key part of treatment for patients with MM. There are two...

Read More

Evaluating outcomes after salvage stem cell transplantation for patients with recurrent multiple myeloma

Posted by on Apr 30, 2019 in Multiple Myeloma | 0 comments

In a nutshell This study evaluated the outcomes of patients with recurrent multiple myeloma (MM) after a stem cell transplant (SCT). This study concluded that these patients had a lower quality of life up to 2 years after treatment. Some background Multiple myeloma is a type of cancer of the bone marrow that can lead to abnormal immune cells. For...

Read More

Evaluating carfilzomib plus dexamethasone for newly diagnosed multiple myeloma

Posted by on Apr 23, 2019 in Multiple Myeloma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of the Kd regimen (carfilzomib, dexamethasone) for patients with newly diagnosed multiple myeloma. This study concluded that this regimen was effective for these patients, with mild side effects. Some background Multiple myeloma (MM) is a type of cancer of the bone marrow that...

Read More

Looking for patients with multiple myeloma to compare 2 conditioning regimens before stem cell transplantation

Posted by on Apr 22, 2019 in Multiple Myeloma | 0 comments

In a nutshell This study is evaluating the effectiveness of melphalan (Alkeran) alone compared to BEAM chemotherapy (carmustine, etoposide, cytarabine, and melphalan) in patients with multiple myeloma before a stem cell transplant (SCT). The main outcome to be measured will be the number of patients who have complete disappearance of all signs of...

Read More

Evaluating ixazomib maintenance therapy for patients with multiple myeloma

Posted by on Apr 19, 2019 in Multiple Myeloma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of ixazomib (Ninlaro) given after a stem cell transplant for patients with multiple myeloma (MM). This study concluded that ixazomib maintenance therapy is effective for these patients, with manageable side effects. Some background Multiple myeloma is a type of cancer of the bone marrow...

Read More

Searching for patients to try a combination treatment for multiple myeloma.

Posted by on Apr 17, 2019 in Multiple Myeloma | 0 comments

In a nutshell The study will investigate the effects of carfilzomib (Kyprolis), pomalidomide (Pomalyst), and dexamethasone (Decadron) in multiple myeloma (MM). The main outcome that will be measured will be the percentage of patients who have no signs or symptoms of MM after treatment (completed response). This study is recruiting in Georgia, Unites...

Read More

A combination of clarithromycin, pomalidomide and dexamethasone in patients with relapsed/unresponsive multiple myeloma

Posted by on Apr 12, 2019 in Multiple Myeloma | 0 comments

In a nutshell This study aimed to investigate the safety and effectiveness of a combination of clarithromycin, pomalidomide, and dexamethasone (the ClaPd regime) in patients with relapsed/unresponsive multiple myeloma who had been treated with lenalidomide. This study concluded that this combination is as effective as other currently used...

Read More